Arizona Tribune - Boulevard

NYSE - LSE

RBGPF	0%	78.35	$
CMSC	0.17%	23.48	$
RYCEF	3.14%	14.67	$
RIO	-0.75%	73.73	$
RELX	0.86%	40.54	$
NGG	-0.76%	75.91	$
AZN	-0.91%	90.03	$
VOD	0.4%	12.64	$
GSK	-0.82%	48.57	$
CMSD	-0.13%	23.32	$
SCS	-0.74%	16.23	$
BCC	-3.1%	74.26	$
BP	-0.03%	37.23	$
BTI	0.91%	58.04	$
JRI	0.36%	13.75	$
BCE	0.17%	23.22	$

Featured

Survivors pick up pieces in flood-hit Indonesia as more rain predicted

Survivors in Indonesia were piecing back shattered lives Friday after devastating floods killed more than 1,500 people across four countries, with fears of fresh misery as more rain looms.

After 15 years, Dutch anti-blackface group declares victory

Cherished Christmas tradition for some, profoundly insulting for others, the Dutch character "Black Pete", a servant who helps Santa Claus distribute presents, has divided opinion in The Netherlands for decades.

Last news

Race to get aid to Asia flood survivors as toll hits 1,300

Governments and aid groups in Indonesia and Sri Lanka worked Tuesday to rush aid to hundreds of thousands stranded by deadly flooding that has killed 1,300 people in four countries.

Tens of thousands flock to pope's Beirut mass

Around 150,000 people gathered at Beirut's waterfront for mass with Pope Leo XIV on Tuesday morning, the highlight of the Catholic leader's visit to the capital, where he delivered a message of hope and peace.

Hong Kong leader says independent committee to probe fire

Hong Kong's leader said on Tuesday that an independent committee will investigate the cause of the city's deadliest fire in decades, after authorities found substandard building materials had accelerated the blaze, which killed 151 people last week.

Pope Leo to hold Beirut mass, visit port blast site

Thousands of Lebanese faithful were making their way to Beirut's waterfront ahead of Pope Leo XIV's mass on Tuesday morning, the highlight of the Catholic leader's visit to the capital expected to draw huge crowds.

'Rescued my soul': Hong Kong firefighters save beloved pets

When Jacky Lee first heard about a raging fire at the Hong Kong housing estate where she lived, she rushed back to save Jason, her 15-year-old grey poodle still at home, fearing she would never see him again.

Survivors, families seek answers to deadly Hong Kong ferry disaster

Survivors of one of Hong Kong's deadliest maritime disasters and victims' families who spent 13 years in a legal and bureaucratic maze seeking answers are hoping a coroner's rulinthis week will shed light on the tragedy.

Hong Kong leader announces 'independent committee' to probe fire

Hong Kong's leader announced Tuesday the creation of a judge-led "independent committee" to investigate the devastating fire at an apartment complex that killed 151 people last week.

VR headsets take war-scarred children to world away from Gaza

Children scarred by the war in Gaza are undergoing a therapy programme using virtual reality headsets that transport the youngsters to a world far away from the destruction around them.

Electronic Caregiver Positions Addison Care as a Transformative Enablement Platform for CMS's New ACCESS Model

LAS CRUCES, NEW MEXICO / ACCESS Newswire / December 2, 2025 / Following CMS's announcement of the new ACCESS Model (Advancing Chronic Care with Effective, Scalable Solutions), Electronic Caregiver, Inc. (ECG) announced its intention to collaborate with eligible Medicare Part B providers and health organizations once CMS releases its list of participating entities in 2026.

President Trump's Most Difficult Marijuana Decision: Why MMJ International Holding Is A Solution

A Geopolitical, Legal, and Public-Health Crisis-and Why MMJ International Holdings Offers a Viable Federal Solution"President Trump is facing an impossible landscape created by years of regulatory neglect. We built a federally compliant, pharmaceutical grade marijuana medicine to bring order to that chaos. MMJ offers the President a path that respects the law, protects patients, and restores integrity to cannabinoid science."-Duane Boise, President & CEO, MMJ International Holdings

Scientists Did Not Recommend a 54% Cut to the Atlantic Menhaden Fishery

They provided risk projections for managers to choose, the chosen 20% TAC reduction yields 0% probability of overfishingUnder the 2020 ERP definitions, Atlantic menhaden are not overfished and overfishing is not occurring. For 2023, fecundity is on the order of 1.2 quadrillion eggs (above the ERP fecundity threshold but below the target) and fishing mortality is about 0.26 (above the ERP F-target but still below the ERP F-threshold). The overview also makes clear there is no single "right" ERP; selecting ERP targets and thresholds is a management choice that balances objectives for menhaden and their predators.The 2025 single-species update applied a lower estimate of natural mortality (M). That change lowers the back-calculated biomass, fecundity, and recruitment across the time series and raises the corresponding fishing mortality (F) estimates, even though the underlying population did not suddenly decline. Because of the revised M, the 2025 assessment's long-term average biomass is about a third lower than the 2022 update's average; this reflects an improved understanding of the stock rather than a real-time drop in the stock itself.The 2025 update shows that the biomass of age-1+ menhaden is just below its 20-year average but has been trending up since 2021.Adult abundance in 2023 was 14.8 billion age-1+ fish, above the average of the past 20 years.Recruitment in 2023 was 44.5 billion age-0 fish, above the average of the past 20 years.

Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms

ORLANDO, FLORIDA / ACCESS Newswire / December 2, 2025 / Exousia Pro, Inc. (OTCID:MAJI), a clinical-stage biotechnology company focused on advanced exosome-based delivery systems, today announced the execution of an exclusive licensing agreement between its wholly owned subsidiary, Exousia Pro Holding Management, LLC, and the University of Central Florida (UCF) concerning its groundbreaking technology for both the diagnosis and treatment of cancer using exosomes.

Karbon-X (KARX) Chooses New to The Street for Monthly Interviews and Nationwide Broadcasts

NEW YORK CITY, NEW YORK / ACCESS Newswire / December 2, 2025 / Karbon-X, Inc. (OTC:KARX), a leader in community-driven carbon reduction and sustainability innovation, has selected New to The Street, one of the nation's most influential multi-platform financial news brands, for a monthly broadcast interview series reaching audiences nationwide and internationally.

The International Surface Event 2026 Returns to Las Vegas to Drive Innovation, Education and Industry Connection

North America's premier flooring, stone and tile event features 650+ global brands, comprehensive education program and cutting-edge show floor demonstrations.

Tchaikovsky's Voice Returns 130 Years Later

A Remarkable Memoir Reveals the Composer's Own Story-Including the Hidden Muse Behind The Nutcracker

Trial Library Raises $10 Million Series A to Expand Access to Clinical Trials as a Care Option

Co-led by SemperVirens Venture Capital and Next Ventures, with participation by Sanofi Ventures, Lux Capital, Civilization Ventures, How Women Invest and other notable investors

ACHR NEWS Announces Inaugural HVAC Contractor Forum in Frisco, Texas

New event, co-located with ACCA's Smart Tech Summit, to deliver practical strategies, networking, and insights for HVAC residential contractors

Medical Care Technologies Inc. (OTC PINK:MDCE) Expands Development of Consumer-Grade AI Pre-Health Screening Tools Focused on Early Detection

MESA, ARIZONA / ACCESS Newswire / December 2, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) announced today that the company is expanding its development efforts into a new generation of consumer-grade AI pre-health screening mobile applications designed to help identify early warning signs of serious health conditions and encourage timely medical intervention.

StimCell Energetics Inc. Announces Study into eBalance(R) Device's Impact on Neuronal Mitochondrial Function

VANCOUVER, BC / ACCESS Newswire / December 2, 2025 / StimCell Energetics Inc. (OTCQB:STME) ("StimCell" or the "Company"), a biotech pioneer targeting cellular energy to enhance wellness, anti-aging, and longevity, today announced the signing of a service agreement with the St. Boniface Hospital Albrechtsen Research Centre, affiliated with the University of Manitoba, and Principal Investigator, Professor Paul Fernyhough. This collaboration will explore the effects of StimCell's proprietary eBalance® device on mitochondrial function in cultured sensory neurons to further define the physiological action of microcurrents.

Aspire Biopharma Submits Pre-IND Meeting Request and Briefing Package to U.S. FDA for Sublingual Aspirin Product for Treatment of Suspected Acute Myocardial Infarction (Heart Attack)

ESTERO, FLORIDA / ACCESS Newswire / December 2, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, is pleased to announce that on November 3, 2025, it submitted its Pre-IND meeting request and briefing package to the U.S. Food and Drug Administration (FDA). The submission concerns the Company's lead product candidate, a fast-acting, high-dose sublingual aspirin formulation for the treatment of suspected acute myocardial infarction (AMI) and represents a significant milestone on the path to potential FDA approval.

Strive Pharmacy Breaks Ground on New 350,000 Sq. Ft. Arizona Headquarters and Compounding Facility, Strengthening Its National Leadership in Patient-Focused Innovation

New Mesa campus deepens Strive's roots in Arizona, expands production capabilities, and accelerates job creation as the company surpasses 700,000 sq. ft. of national operations.

Who Does the Best Tummy Tuck in Sarasota?

The Best Tummy Tuck in Sarasota is by Dr. Sessa

Jaguar Health Makes Submission to EMA Regarding EU Approval Pathway for Canalevia for General Diarrhea in Dogs Based on Data from Completed Study

Jaguar's requesting advice from EMA on EU approval pathway for general diarrhea of FDA conditionally approved Canalevia®A novel non-antibiotic approach to diarrhea treatment is important because there are no FDA-approved drugs to treat general diarrhea in dogs, the second most common reason for visits to veterinary emergency hospitals

NGCG Announces Development of Spiritual Glow Smartphone Application by Signature Apps

PHOENIX, AZ / ACCESS Newswire / December 2, 2025 / New Generation Consumer Group, Inc. (OTCID:NGCG) is pleased to announce that Signature Apps, the Company's technology and development subsidiary, has officially begun work on a dedicated smartphone application for Spiritual Glow, NGCG's recently announced acquisition in the wellness and spiritual lifestyle sector.

DDC's Two Month Reset Turned a Volatile Story Into a Ripe Opportunity

NEW YORK, NY / ACCESS Newswire / December 2, 2025 / Every cycle forces investors to rethink what a modern consumer company should look like. Some names respond with tighter cost controls, some with brand refreshes, and some with a full structural overhaul. DDC Enterprise Limited (NYSE American:DDC) sits in that last category. It isn't trying to polish its past. It is trying to rebuild the architecture underneath it. That kind of ambition creates discomfort, curiosity, and attention at the same time.

Stemtech Corporation Announces Entry into China in a Joint Venture with Lightway Ventures

NAPLES, FL / ACCESS Newswire / December 2, 2025 / Stemtech Corporation, the global leader and pioneer in stem cell nutrition, is proud to announce a key strategic agreement to open a joint venture to establish distribution of Stemtech Products in China with Lightway Ventures. Stemtech Asia (Hong Kong) is being established, subject to final funding and regulatory approvals, and will be under the corporate structure of Stemtech Corporation, a Nevada USA holding company (OTCQB: "STEK").

Dogwood Therapeutics Files New Synthetic Halneuron(R) Intellectual Property Protection Projected to Extend Exclusivity Period Up to 2045

- New Composition of Matter Intellectual Property ("IP") Filing Centered on First-in-Class, Fully Synthetically Manufactured Halneuron®-- New Synthetic Process to be Used for Phase 3 Development Provides Higher Manufacturing Yields and Reduces Costs Versus Naturally Harvested Halneuron® -

Ensysce Biosciences Announces Broader Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology

~ New U.S. Patent Extends Protection Through 2042 ~~ Patent Allowance Secures Highest Level of Intellectual Property Protection for MPAR® ~

Doctor Becomes First in Illinois to Perform Revolutionary, Minimally Invasive Bladder Control Procedure

DOWNERS GROVE, IL / ACCESS Newswire / December 2, 2025 / Dr. Sarah Martin, a women's urology specialist at Duly Health and Care's Chicagoland medical group, DuPage Medical Group, Ltd., this month became the first physician in Illinois to perform a cutting-edge, minimally invasive bladder control procedure using the Altaviva™ implant.

Avel eCare Welcomes Pat Gundersen as New Chief Revenue Officer

SIOUX FALLS, SD / ACCESS Newswire / December 2, 2025 / Avel eCare is pleased to announce the appointment of Pat Gundersen as its new Chief Revenue Officer, bringing more than twenty years of leadership experience in healthcare, healthcare technology, and go-to-market strategy.

Organto Foods Highlights Strong Growth Momentum and Strategic Evolution Following Successful Restructuring

Focused on advancing its strategy for sustainable, scalable expansion, the Company unveils its refreshed brand identity, outlines its integrated farm-to-shelf model and details its disciplined path for future growth.

CBD Life Sciences Inc. (CBDL) CEO Lisa Nelson Interviews With The Morning Show

"Inside the explosive rise of a wellness company outpacing a $200B+ global market"Watch the full Morning Show interview →

Arizona Tribune - Boulevard (English)